13F HOLDINGS REPORT
Patient Square Capital LP
Quarter ended Q4 2025 · Filed February 12, 2026 · Accession 0001819257-26-000002
Total Value
$467.1M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | ROIV | 8,166,047 | $177.2M | 37.93% |
| 2 | INSMED INC | INSM | 267,000 | $46.5M | 9.95% |
| 3 | MIRUM PHARMACEUTICALS INC | MIRM | 298,682 | $23.6M | 5.05% |
| 4 | ARGENX SE | ARGX | 26,000 | $21.9M | 4.68% |
| 5 | BEONE MEDICINES LTD | BEIGF | 69,312 | $21.1M | 4.51% |
| 6 | ABIVAX SA | AAVXF | 130,000 | $17.5M | 3.75% |
| 7 | PHARVARIS N V | PHVS | 542,696 | $15.1M | 3.22% |
| 8 | EYEPOINT INC | EYPT | 780,000 | $14.3M | 3.05% |
| 9 | TERNS PHARMACEUTICALS INC | TERN | 320,000 | $12.9M | 2.77% |
| 10 | CELCUITY INC | CELC | 120,000 | $12.0M | 2.56% |
| 11 | COGENT BIOSCIENCES INC | COGT | 317,372 | $11.3M | 2.41% |
| 12 | KYMERA THERAPEUTICS INC | KYMR | 139,000 | $10.8M | 2.32% |
| 13 | LIQUIDIA CORPORATION | LQDA | 227,000 | $7.8M | 1.68% |
| 14 | DBV TECHNOLOGIES S A | DBVTF | 359,050 | $6.9M | 1.47% |
| 15 | ALLOGENE THERAPEUTICS INC | ALLO | 4,963,756 | $6.8M | 1.46% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 150,000 | $6.2M | 1.32% |
| 17 | XENON PHARMACEUTICALS INC | XENE | 136,500 | $6.1M | 1.31% |
| 18 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 210,000 | $6.1M | 1.31% |
| 19 | OCULAR THERAPEUTIX INC | OCUL | 490,000 | $5.9M | 1.27% |
| 20 | DISC MEDICINE INC | IRON | 74,000 | $5.9M | 1.26% |
| 21 | AVALO THERAPEUTICS INC | AVTX | 311,966 | $5.7M | 1.21% |
| 22 | SPYRE THERAPEUTICS INC | SYRE | 150,000 | $4.9M | 1.05% |
| 23 | ENLIVEN THERAPEUTICS INC | ELVN | 308,141 | $4.7M | 1.02% |
| 24 | ASSEMBLY BIOSCIENCES INC | ASMB | 127,000 | $4.3M | 0.92% |
| 25 | AMYLYX PHARMACEUTICALS INC | AMLX | 350,000 | $4.2M | 0.91% |
| 26 | ARCUS BIOSCIENCES INC | RCUS | 170,000 | $4.1M | 0.87% |
| 27 | PERSPECTIVE THERAPEUTICS INC | CATX | 1,132,815 | $3.1M | 0.67% |
| 28 | HARROW INC | HROW | 7,031 | $344,519 | 0.07% |